COMPLEMENT C5

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 13:22:20 GMT 2023` Edited by `admin` on `Sat Dec 16 13:22:20 GMT 2023`
Protein Sub Type
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	7A6G4V3R84
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

COMPLEMENT C5

Common Name

English

CPAMD4

Common Name

English

COMPLEMENT COMPONENT 5

Common Name

English

Code System Code Type Description

FDA UNII

7A6G4V3R84

Created by admin on Sat Dec 16 13:22:20 GMT 2023 , Edited by admin on Sat Dec 16 13:22:20 GMT 2023

PRIMARY

CAS

80295-53-0

Created by admin on Sat Dec 16 13:22:20 GMT 2023 , Edited by admin on Sat Dec 16 13:22:20 GMT 2023

PRIMARY

From	To
1_21	1_47
1_22	1_54
1_133	2_549
1_179	1_206
1_189	1_850
1_424	1_482
1_698	1_828
1_728	1_797
1_843	1_848
1_855	1_929
1_876	1_999
1_977	1_980
2_616	2_651
1_34	1_55

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_64
N	1_234
N	1_438
N	1_953

Related Record Type Details


					6PWU78BV6C

LIGAND->TARGET

Interaction Type:

PRECLINICAL

Amount:


					YG391PK0CC

INHIBITOR -> TARGET

Amount:


					3FO6689MSD

INHIBITOR -> TARGET


					2Y94876JAR

Ergidina

INHIBITOR -> TARGET

Amount:


					A3ULP0F556

INHIBITOR -> TARGET

Interaction Type:

BLOCKER


					2YUH7KM2C2

LIGAND->TARGET

Amount:


					5JUR4M77U7

MUBODINA

INHIBITOR -> TARGET

Amount:


					79V7Q9VIWQ

NOMACOPAN

INHIBITOR -> TARGET

Interaction Type:

ANTAGONIST


					C3VX249T6L

INHIBITOR -> TARGET


					S66Z65E10T

INHIBITOR -> TARGET

Amount:


					0JJ21K6L2I

POZELIMAB

INHIBITOR -> TARGET

Amount:


					H9KH1GP3UU

INHIBITOR -> TARGET


					G3PS38JMS8

Vensobafusp alfa

INHIBITOR -> TARGET

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL